Ali Behbahani - Jul 5, 2023 Form 4 Insider Report for Black Diamond Therapeutics, Inc. (BDTX)

Role: Director
Signature: /s/ Louis Citron, attorney-in-fact
Stock symbol: BDTX
Transactions as of: Jul 5, 2023
Transactions value $: $5,000,000
Form type: 4
Date filed: 7/6/2023, 04:45 PM
Previous filing: Jul 3, 2023
Next filing: Jul 19, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BDTX	Common Stock	Purchase	$5M	+1M	+29%	$5.00	4.45M	Jul 5, 2023	See Note 2	F1, F2
holding	BDTX	Common Stock						40.8K	Jul 5, 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reports the purchase of shares in the underwritten public offering of common stock of the Issuer.
F2	The Reporting Person is a manager of NEA 16 GP, LLC ("NEA 16 GP"), which is the sole general partner of NEA Partners 16, L.P. ("NEA Partners 16"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. ("NEA 16"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest.

Content

Reports the purchase of shares in the underwritten public offering of common stock of the Issuer.

The Reporting Person is a manager of NEA 16 GP, LLC ("NEA 16 GP"), which is the sole general partner of NEA Partners 16, L.P. ("NEA Partners 16"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. ("NEA 16"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest.